It is noteworthy that in BRCA, pheochromocytoma and paraganglioma (PCPG), and SARC, patients in the CNN1 high-expression group had better OS than those in the CNN1 low-expression group (p < 0.05). Here, CNN1 is linked to paraganglioma.